COVID-19 convalescent plasma from Norwegian blood donors

Lise Sofie H Nissen-Meyer; Tor Hervig; Børre Fevang; Gunnstein Norheim; Anne-Marte Bakken Kran; John Torgils Vaage; Øystein Flesland

doi:10.4045/tidsskr.22.0057

COVID-19 convalescent plasma from Norwegian blood donors

Tidsskr Nor Laegeforen. 2022 Jun 13;142(9). doi: 10.4045/tidsskr.22.0057. Print 2022 Jun 14.

[Article in English, Norwegian]

Authors

Lise Sofie H Nissen-Meyer, Tor Hervig, Børre Fevang, Gunnstein Norheim, Anne-Marte Bakken Kran, John Torgils Vaage, Øystein Flesland

PMID: 35699539
DOI: 10.4045/tidsskr.22.0057

No abstract available

Plain language summary

The collection and use of convalescent plasma to treat COVID-19 has taught us important lessons about the organisation, testing and selection of blood donors and patients. This is knowledge that can be used in the next pandemic.

MeSH terms

Antibodies, Viral
Blood Donors*
COVID-19 Serotherapy
COVID-19* / therapy
Humans
Immunization, Passive
SARS-CoV-2

Substances

Antibodies, Viral